The need is, therefore, to boost patient awareness. This can be achieved through extensive workshops and disease awareness programmes.
"In conjunction with medical research organisations and hospitals, manufacturers should establish awareness programmes and interactive workshops for the public," advises Ramanathan. "These could highlight the prevalence of autoimmune diseases, while encouraging physicians to interact with the public on the symptoms, etiology and progression of autoimmune diseases."
If you are interested in a virtual brochure, which provides manufacturers, end users and other industry participants with an overview of the European autoimmune disease diagnostics market, then send an e-mail to Patrick Cairns, Corporate Communications, at firstname.lastname@example.org, with your full name, company name, title, telephone number, company e-mail address, company website, city, state and country. Upon receipt of the above information, an overview will be sent to you by e-mail.
Strategic Analysis of the European Autoimmune Disease Diagnostics Market is part of the Drug Discovery & Clinical Diagnostics Growth Partnership Services programme, which also includes research in the following markets: European POC Connectivity Market, European Immunoassay Diagnostics Market, Western European IVD Markets, and Eastern European IVD Markets. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants. Interviews with the press are available.
Frost & Sullivan, the Growth Partnership Compa
|SOURCE Frost & Sullivan|
Copyright©2008 PR Newswire.
All rights reserved